Among the downregulated signature genes, low expression of CSTA and HSPB8 was correlated with unfavorable outcomes in HER2-positive breast cancer, while no correlation was observed with outcome in all breast cancers. This evidence concerns the gene HSPB8 and breast carcinoma.